The California Senate recently cleared a bill to bar pharmacy benefit manager (PBM) alleged discrimination against 340B covered entities and [...] …
Month: September 2023
An attorney for the state of Arkansas recently told a federal appeals court that the state will enforce its 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Merck recently announced that it owes refunds to 340B covered entities for purchases of 17 products during the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Where did you grow up?
Kalamazoo, Michigan
Q: Where did you go to college/graduate school?
University of Michigan
Q: What are your favorites?
Food: Homemade apple
…
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Inaccurate points were ascribed to 340B advisers and service providers in a recent legal filing by four drugmakers as part [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Powers Law Firm is proud to support an unparalleled learning opportunity for 340B grantees. The 340B Grantees Fall Conference, hosted by Ryan White Clinics for 340B Access, the National Association of Community Health Centers, and the State and Regional Associations
…
A federal appeals court decision striking down parts of an Oklahoma pharmacy benefit manager (PBM) law could jeopardize state laws [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Janssen Biotech recently determined that it owes or may owe refunds to some 340B covered entities. The refunds [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eligible covered entities in Florida may enroll in the 340B program immediately rather than having to wait for the next [...] …